Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 18/20 | 0.74 |
| ▸ | RAF1 | P04049 | 2/20 | 0.54 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.51 |
| ▸ | IGF1R | P08069 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7001584 | 0.89 | MAP2K1 (0.73) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL7003384 | 0.88 | MAP2K1 (0.74) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL6994143 | 0.88 | MAP2K1 (0.73) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL7003202 | 0.88 | MAP2K1 (0.75) | MAP2K1RAF1MAPK3MAPK1IGF1R | |
| SCHEMBL6995302 | 0.88 | MAP2K1 (0.75) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL6998933 | 0.88 | MAP2K1 (0.75) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL6992075 | 0.86 | MAP2K1 (0.75) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL7001922 | 0.85 | MAP2K1 (0.59) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL4456367 | 0.85 | MAP2K1 (1.00) | MAP2K1RAF1MAPK3MAPK1EGFR | |
| SCHEMBL7003056 | 0.85 | MAP2K1 (0.58) | MAP2K1RAF1MAPK3MAPK1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1117659-B1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | WYETH CORP (US) | 2003-12-03 | — | — | EP | claimed |